Ananda Pharma Plc (AQU:ANA)

Ananda Pharma Income Statement

Financials in millions GBP. Fiscal year is February - January.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Operating Revenue	0	-	-	-	-
Other Revenue	-0	-	-	-	-
Revenue	0	-	-	-	-
Gross Profit	0	-	-	-	-
Selling, General & Admin	2.94	1.78	0.84	0.97	0.5
Operating Expenses	3.57	2.97	1.01	0.97	0.5
Operating Income	-3.57	-2.97	-1.01	-0.97	-0.5
Interest Expense	-0.22	-0.14	-0.25	-	-
Interest & Investment Income	0.02	0	-	-	0
Currency Exchange Gain (Loss)	-	-	-	-0	0
EBT Excluding Unusual Items	-3.77	-3.11	-1.26	-0.97	-0.5
Impairment of Goodwill	-	-1.01	-	-	-
Asset Writedown	-	-2.81	-0.04	-	-
Pretax Income	-3.77	-6.93	-1.3	-0.97	-0.5
Income Tax Expense	-	-0.78	-	-	-
Net Income	-3.77	-6.15	-1.3	-0.97	-0.5
Net Income to Common	-3.77	-6.15	-1.3	-0.97	-0.5
Shares Outstanding (Basic)	3,803	2,631	851	722	446
Shares Outstanding (Diluted)	3,803	2,631	851	722	446
Shares Change (YoY)	44.54%	209.17%	17.94%	61.93%	15.39%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	-0.82	-0.72	-0.46	-	-
Free Cash Flow Per Share	-	-	-0.00	-	-
Gross Margin	100.00%	-	-	-	-
Operating Margin	-5759653.23%	-	-	-	-
Profit Margin	-6081430.64%	-	-	-	-
Free Cash Flow Margin	-1316750.00%	-	-	-	-
EBITDA	-3.35	0.45	-0.84	-	-
D&A For EBITDA	0.22	3.42	0.17	-	-
EBIT	-3.57	-2.97	-1.01	-0.97	-0.5

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.